Factors with a negative impact on the long-term outcome are a reduced response to neoadjuvant chemotherapy as expressed by a smaller decrease of AFP in the subgroup of hepatoblastoma patients and transplantation as salvage transplantation. This evidence concerns the gene AFP and hepatoblastoma.